---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-004105"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2023-01-20T23:59:59+00:00"
generated_at: "2026-06-20T12:40:08.187112+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics: three directors resign, board size reduced to 5; annual meeting adjourned to Feb 3

## Summary
- Directors Duncan Moore and Gail Maderis resigned Jan 19, 2023; Soren G. Jensen resigns effective Feb 4, 2023.
- Board reduced fixed number of authorized directors from 7 to 5 following the resignations.
- 2023 annual meeting adjourned on Jan 19 without business; reconvenes Feb 3, 2023 for additional voting time.
- Resignations stated as for personal reasons, not due to disagreements with company operations or policies.

## SEC filing metadata
- accession: 0001213900-23-004105
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2023-01-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/ea171929-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-004105
- JSON: https://secwatch.observer/filing/0001213900-23-004105.json
- Plain text: https://secwatch.observer/filing/0001213900-23-004105.txt

## Key facts
- Executive change
  Gail Maderis resigned as Director at Allarity Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm
- Executive change
  Duncan Moore resigned as Director at Allarity Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm
- Executive change
  Soren G. Jensen resigned as Director at Allarity Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 19, 2023, Mr. Soren G. Jensen gave notice that he will resign as a director, to be effective as of February 4, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.